165 related articles for article (PubMed ID: 31047032)
1. The Molecular Biologic Basis of Esophageal and Gastric Cancers.
Pennathur A; Godfrey TE; Luketich JD
Surg Clin North Am; 2019 Jun; 99(3):403-418. PubMed ID: 31047032
[TBL] [Abstract][Full Text] [Related]
2. DNA copy number profiling in esophageal Barrett adenocarcinoma: comparison with gastric adenocarcinoma and esophageal squamous cell carcinoma.
Varis A; Puolakkainen P; Savolainen H; Kokkola A; Salo J; Nieminen O; Nordling S; Knuutila S
Cancer Genet Cytogenet; 2001 May; 127(1):53-8. PubMed ID: 11408066
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers and staging of early esophageal cancer.
Hosch SB; Stoecklein NH; Izbicki JR
Langenbecks Arch Surg; 2003 Apr; 388(2):77-82. PubMed ID: 12712339
[TBL] [Abstract][Full Text] [Related]
5. Early Barrett's carcinoma of the esophagus.
Hölscher AH; Vallböhmer D; Bollschweiler E
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
[No Abstract] [Full Text] [Related]
6. Molecular biology of esophageal cancer.
Metzger R; Schneider PM; Warnecke-Eberz U; Brabender J; Hölscher AH
Onkologie; 2004 Apr; 27(2):200-6. PubMed ID: 15138356
[TBL] [Abstract][Full Text] [Related]
7. Growth factors and oncogenes in Barrett's oesophagus and gastric metaplasia.
Filipe MI; Jankowski J
Endoscopy; 1993 Nov; 25(9):637-41. PubMed ID: 8119221
[No Abstract] [Full Text] [Related]
8. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
Ruol A; Merigliano S; Baldan N; Santi S; Petrin GF; Bonavina L; Ancona E; Peracchia A
Dis Esophagus; 1997 Jul; 10(3):190-5. PubMed ID: 9280078
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
10. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
11. The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg?
Russo A; Bronte G; Cabibi D; Bazan V; Cicero G; Bertani A; Rizzo S; Fiorentino E
Crit Rev Oncol Hematol; 2013 Jun; 86(3):278-89. PubMed ID: 23290822
[TBL] [Abstract][Full Text] [Related]
12. Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma.
Moskaluk CA; Rumpel CA
Cancer; 1998 Jul; 83(2):232-9. PubMed ID: 9669804
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
14. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma.
Greenawalt DM; Duong C; Smyth GK; Ciavarella ML; Thompson NJ; Tiang T; Murray WK; Thomas RJ; Phillips WA
Int J Cancer; 2007 May; 120(9):1914-21. PubMed ID: 17236199
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
[TBL] [Abstract][Full Text] [Related]
17. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma.
Rajendra S; Sharma P
Hematol Oncol Clin North Am; 2017 Jun; 31(3):409-426. PubMed ID: 28501084
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cancer-activating genes on chromosomes 7 and 8 in esophageal (Barrett's) and gastric cardia adenocarcinoma.
Vissers KJ; Riegman PH; Alers JC; Tilanus HW; van Dekken H
Anticancer Res; 2001; 21(6A):3813-20. PubMed ID: 11911252
[TBL] [Abstract][Full Text] [Related]
19. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
Wang LD; Zheng S; Zheng ZY; Casson AG
World J Gastroenterol; 2003 Jun; 9(6):1156-64. PubMed ID: 12800215
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
